PT87820A - Process for the preparation of 1,2,3,5,6-tetrahydro-pyridile anof pyperidile compounds and pharmaceutical compositions therewi - Google Patents

Process for the preparation of 1,2,3,5,6-tetrahydro-pyridile anof pyperidile compounds and pharmaceutical compositions therewi

Info

Publication number
PT87820A
PT87820A PT87820A PT8782088A PT87820A PT 87820 A PT87820 A PT 87820A PT 87820 A PT87820 A PT 87820A PT 8782088 A PT8782088 A PT 8782088A PT 87820 A PT87820 A PT 87820A
Authority
PT
Portugal
Prior art keywords
pyperidile
pyridile
anof
therewi
tetrahydro
Prior art date
Application number
PT87820A
Other languages
English (en)
Other versions
PT87820B (pt
Inventor
Klaus Peter Bogeso
Klaus Gundertofte Jensen
Ejner Knud Moltzen
Henrik Pedersen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of PT87820A publication Critical patent/PT87820A/pt
Publication of PT87820B publication Critical patent/PT87820B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
PT87820A 1987-06-24 1988-06-24 Processo para a preparacao de compostos de1,2,5,6-tetrahidropiridilo e de piperidilo e de composicoes farmaceuticas que os contem PT87820B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878714789A GB8714789D0 (en) 1987-06-24 1987-06-24 Heterocyclic compounds

Publications (2)

Publication Number Publication Date
PT87820A true PT87820A (pt) 1989-05-31
PT87820B PT87820B (pt) 1992-10-30

Family

ID=10619472

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87820A PT87820B (pt) 1987-06-24 1988-06-24 Processo para a preparacao de compostos de1,2,5,6-tetrahidropiridilo e de piperidilo e de composicoes farmaceuticas que os contem

Country Status (19)

Country Link
US (3) US4866077A (pt)
EP (1) EP0296721B1 (pt)
JP (1) JP2703268B2 (pt)
AU (1) AU615917B2 (pt)
BR (1) BR1100658A (pt)
CA (1) CA1340458C (pt)
DE (1) DE3881970T2 (pt)
DK (1) DK168600B1 (pt)
ES (1) ES2056928T3 (pt)
FI (1) FI93356C (pt)
GB (1) GB8714789D0 (pt)
HK (1) HK84194A (pt)
HU (1) HU210809A9 (pt)
IE (1) IE61694B1 (pt)
IL (1) IL86618A (pt)
NO (1) NO174051C (pt)
NZ (1) NZ224868A (pt)
PT (1) PT87820B (pt)
ZA (1) ZA884339B (pt)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3877470T2 (de) * 1987-09-10 1993-06-24 Merck Sharp & Dohme Oxazole und thiazole zur behandlung seniler demenz.
IE63906B1 (en) * 1987-11-13 1995-06-14 Novo Nordisk As Azabicyclic compounds and their preparation and use
ATE87918T1 (de) * 1988-02-19 1993-04-15 Lilly Co Eli Tetrazolverbindungen als antagonisten der excitatorischen aminosaeurerezeptoren.
DK162892C (da) * 1988-07-04 1992-05-11 Novo Nordisk As 1,2,5,6-tetrahydropyridinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende disse
IT1229491B (it) * 1988-12-28 1991-09-03 Roussel Maestretti S P A Ora R Derivati della 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro impiego come sostanze medicinali
JP3003148B2 (ja) * 1989-01-05 2000-01-24 藤沢薬品工業株式会社 チアゾール化合物、その製造法およびそれを含有する医薬組成物
US4902695A (en) * 1989-02-13 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
US5264444A (en) * 1989-02-22 1993-11-23 Novo Nordisk A/S Piperidine compounds and use
US5260311A (en) * 1989-02-22 1993-11-09 Novo Nordisk A/S Piperidine compounds and their use
US5328925A (en) * 1989-02-22 1994-07-12 Novo Nordisk A/S Piperidine compounds and their use
EP0402056A3 (en) * 1989-06-06 1991-09-04 Beecham Group p.l.c. Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them
ATE136031T1 (de) * 1989-10-07 1996-04-15 Beecham Group Plc Azabizyklische verbindungen, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
US5200419A (en) * 1990-05-21 1993-04-06 Warner-Lambert Company Substituted tetrazoles and derivatives thereof acting at muscarinic receptors
IE911994A1 (en) * 1990-07-03 1992-01-15 Akzo Nv 5-isothiazolamine derivatives
US5418240A (en) * 1990-08-21 1995-05-23 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
DK198490D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
DK198390D0 (da) 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5527813A (en) * 1990-08-21 1996-06-18 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
US5376668A (en) * 1990-08-21 1994-12-27 Novo Nordisk A/S Heterocyclic compounds
USRE35822E (en) * 1990-08-21 1998-06-09 Novo Nordisk A/S Heterocyclic compounds
ATE164519T1 (de) * 1990-11-29 1998-04-15 Allergan Inc Verwendung von pyridine derivate zur behandlung der okulären hypertomie
EP0576611A4 (en) * 1991-03-13 1996-01-24 Univ Minnesota Radiopharmaceutical agents for the detection of alzheimer's disease
IE922270A1 (en) * 1991-07-26 1993-01-27 Akzo Nv Pyrazole derivatives
US5641791A (en) * 1991-08-13 1997-06-24 Novo Nordisk A.S Heterocyclic compounds and their preparation and use
US5175166A (en) * 1991-08-27 1992-12-29 The University Of Toledo Muscarinic agonists
WO1993014089A1 (en) * 1992-01-13 1993-07-22 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
US5330994A (en) * 1992-03-24 1994-07-19 Warner-Lambert Company Tetrahydropyridine isoxazoline derivatives
DE69325662T2 (de) * 1992-10-23 2000-02-10 Merck Sharp & Dohme Dopamin rezeptor subtyp liganden
US5753683A (en) * 1993-08-19 1998-05-19 Novo Nordisk A/S Antipsychotic method
US5612351A (en) * 1994-11-08 1997-03-18 Novo Nordisk A/S Method of treating urinary bladder dysfunctions
US5668148A (en) * 1995-04-20 1997-09-16 Merck & Co., Inc. Alpha1a adrenergic receptor antagonists
WO1997001555A1 (en) * 1995-06-29 1997-01-16 Novo Nordisk A/S Novel substituted azacyclic compounds
WO1997017074A1 (en) * 1995-11-06 1997-05-15 H. Lundbeck A/S Treatment of traumatic brain injury
WO1997040045A1 (en) * 1996-04-24 1997-10-30 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
US5733912A (en) * 1997-02-19 1998-03-31 Abbott Laboratories 7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission
EP1014974B1 (en) * 1997-05-29 2004-08-11 H. Lundbeck A/S Treatment of schizophrenia and psychosis
AR013096A1 (es) * 1997-07-01 2000-12-13 Lundbeck & Co As H Sal de adicion de acido maleico de 5-(2-etil-2-h-tetrazol-5-il)-1-metil- 1,2,3,6-tetrahidropiridina, composicion farmaceutica que la contiene, su usoen terapia y metodo de preparacion de la misma.
EP1017386A1 (en) * 1997-10-02 2000-07-12 H. Lundbeck A/S GRANULAR PREPARATIONS OF 5-(2-ETHYL- 2$i(H)-TETRAZOL- 5-YL)-1-METHYL-1, 2,3,6-TETRAHYDROPYRIDINE
PL366197A1 (en) * 1998-07-27 2005-01-24 Eli Lilly And Company Treatment of anxiety disorders
AR025353A1 (es) * 1999-08-23 2002-11-20 Lundbeck & Co As H Tratamiento de la incontinencia urinaria
WO2001078723A1 (en) * 2000-04-12 2001-10-25 Smithkline Beecham Corporation Compounds and methods
WO2002085897A1 (en) * 2001-04-05 2002-10-31 Alangudi Sankaranarayanan Heterocyclic compounds for aging-related and diabetic vascular complications
US20030069597A1 (en) * 2001-10-10 2003-04-10 Scimed Life Systems, Inc. Loading tool
WO2003043987A2 (en) * 2001-11-19 2003-05-30 Elan Pharmaceuticals, Inc. (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
MXPA05006426A (es) 2002-12-18 2005-09-08 Fmc Corp N-(arilmetil sustituido)-4-(metil disustituido) piperidina y piperazinas.
WO2004058148A2 (en) * 2002-12-20 2004-07-15 Merck & Co., Inc. Mitotic kinesin inhibitors
CN1980929A (zh) * 2004-02-24 2007-06-13 比奥阿克松医疗技术股份有限公司 4－取代哌啶衍生物
US20060224175A1 (en) * 2005-03-29 2006-10-05 Vrba Anthony C Methods and apparatuses for disposition of a medical device onto an elongate medical device
WO2007025177A2 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
US7985756B2 (en) 2005-10-21 2011-07-26 Braincells Inc. Modulation of neurogenesis by PDE inhibition
WO2007053596A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
JP2009536667A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド ５ｈｔ受容体介在性の神経新生
BRPI0716604A2 (pt) 2006-09-08 2013-04-09 Braincells Inc combinaÇÕes contendo um derivado de 4-acilaminopiridina
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
EP2150543A2 (en) * 2007-04-24 2010-02-10 Solvay Pharmaceuticals B.V. Heterocyclic compounds with affinity to muscarinic receptors
US8084473B2 (en) 2007-04-24 2011-12-27 Solvay Pharmaceuticals B.V. Heterocyclic compounds with affinity to muscarinic receptors
JP2011520905A (ja) 2008-05-15 2011-07-21 ザ・ユニバーシティ・オブ・トレド 向知性剤としてのムスカリンアゴニスト
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EA201171368A1 (ru) * 2009-05-07 2012-04-30 Торрент Фармасьютикалз Лимитед Новые гетероциклические соединения
ES2603032T3 (es) 2010-07-15 2017-02-23 Bayer Intellectual Property Gmbh Compuestos de 3-piridil-heteroarilcarboxamida como pesticidas
EP2630133A1 (de) 2010-10-22 2013-08-28 Bayer Intellectual Property GmbH Neue heterocylische verbindungen als schädlingsbekämpfungsmittel
US9549928B2 (en) 2011-04-29 2017-01-24 The University Of Toledo Muscarinic agonists as enhancers of cognitive flexibility
CN103848850B (zh) * 2013-08-28 2016-03-23 沈阳东瑞精细化工有限公司 一种舒巴坦的制备方法
US10149856B2 (en) 2015-01-26 2018-12-11 BioAxone BioSciences, Inc. Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
US10857157B2 (en) 2015-01-26 2020-12-08 BioAxone BioSciences, Inc. Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
US10106525B2 (en) 2015-01-26 2018-10-23 BioAxone BioSciences, Inc. Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
US11198680B2 (en) 2016-12-21 2021-12-14 BioAxone BioSciences, Inc. Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
WO2019014322A1 (en) 2017-07-11 2019-01-17 BioAxone BioSciences, Inc. KINASE INHIBITORS FOR THE TREATMENT OF DISEASES

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2659739A (en) 1950-04-14 1953-11-17 Eastman Kodak Co 1-hydroxy-4-beta-cyanopropylamino-anthraquinone and process for preparing same
BE845612A (fr) * 1976-03-23 1977-02-28 Derives de tetrazole-5-carboxamide et leur preparation
US4431653A (en) 1982-03-18 1984-02-14 Hoffmann-La Roche Inc. Penicillanic acid derivatives
DE3421072A1 (de) * 1984-06-06 1985-12-12 Heinrich Mack Nachf., 7918 Illertissen 1,4:3,6-dianhydro-hexit-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4650805A (en) * 1985-12-02 1987-03-17 Warner-Lambert Company 4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines and 4-(hexahydro-1-alkyl-3-pyridinyl)-2-thiazolamines having anti-psychotic activity
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
GB8610432D0 (en) * 1986-04-29 1986-06-04 Akzo Nv Amino-thiazole & oxazole derivatives
IL83275A (en) * 1986-09-08 1994-02-27 Novo Nordisk As Compounds 1,2, 4-Oxadiazolyl Pipridine Transformed, their preparation and pharmaceutical preparations containing them
IE63906B1 (en) * 1987-11-13 1995-06-14 Novo Nordisk As Azabicyclic compounds and their preparation and use
EP0372125A1 (en) * 1988-11-08 1990-06-13 Akzo N.V. Oxazole and thiazole derivatives

Also Published As

Publication number Publication date
US4925858A (en) 1990-05-15
PT87820B (pt) 1992-10-30
IE881631L (en) 1988-12-24
BR1100658A (pt) 1999-08-31
IL86618A0 (en) 1988-11-30
HU210809A9 (en) 1995-08-28
FI93356B (fi) 1994-12-15
US4866077A (en) 1989-09-12
AU615917B2 (en) 1991-10-17
CA1340458C (en) 1999-03-23
NZ224868A (en) 1990-07-26
DK321688A (da) 1988-12-25
FI93356C (fi) 1995-03-27
IE61694B1 (en) 1994-11-16
NO882799L (no) 1988-12-27
JP2703268B2 (ja) 1998-01-26
AU1828288A (en) 1989-01-05
EP0296721A3 (en) 1990-04-25
GB8714789D0 (en) 1987-07-29
NO174051B (no) 1993-11-29
NO174051C (no) 1994-03-09
IL86618A (en) 1992-07-15
ES2056928T3 (es) 1994-10-16
DK168600B1 (da) 1994-05-02
FI883064A0 (fi) 1988-06-23
USRE36374E (en) 1999-11-02
DE3881970D1 (de) 1993-07-29
ZA884339B (en) 1989-05-30
FI883064A (fi) 1988-12-25
HK84194A (en) 1994-08-26
DE3881970T2 (de) 1993-11-11
EP0296721B1 (en) 1993-06-23
DK321688D0 (da) 1988-06-13
EP0296721A2 (en) 1988-12-28
JPS6422869A (en) 1989-01-25
NO882799D0 (no) 1988-06-23

Similar Documents

Publication Publication Date Title
PT87820A (pt) Process for the preparation of 1,2,3,5,6-tetrahydro-pyridile anof pyperidile compounds and pharmaceutical compositions therewi
PT84964A (en) Process for the preparation of 1,5-diaryl-3-substituted-pyrazoles and of pharmaceutical compositions containing them
NO174239C (no) Fremgangsmåte for fremstilling av et oralt, farmasöytisk preparat
HUT50339A (en) Process for producing benzoxazole derivatives and pharmaceutical compositions comprising the compounds
FI890282A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
HU896444D0 (en) Process for the preparation of pharmaceutical compositions
NO871640D0 (no) Fremgangsmaate for fremstilling av n-(2[-aminofenyl)-benzamidderivater.
PT86750A (pt) Process for the preparation of 2-benzoylcyclic-1,3-dione derivatives and of herbicidal compositions containing the same
PT87470A (pt) Process for the preparation of novel substituted benzamides and of pharmaceutical compositions containing the same
PT84041A (en) Process for the preparation of optically pure s-(-)-1-propyl-2:,6:-pipecoloxylidide hydrochloride monohydrate and of pharmaceutical compositions containing the same
FI880467A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
PT87024A (pt) Process for the preparation of propiolophenone derivatives and of pharmaceutical compositions containing the same
IT1218065B (it) Procedimento per pa preparazione di 1,2,5,6,9,10 esabromociclododecano
PT88682A (pt) A process for the preparation of pharmaceutical compositions containing a piperidinoalkanol-decongestant combination
PT88681A (pt) A process for the preparation of pharmaceutical compositions containing piperidinoalkanol derivatives
PT84184A (pt) Process for the preparation of 8 alpha-acylaminoergolines and of pharmaceutical compositions containing them
PT76870B (en) Process for the preparation of 1,4-dihydropiridine derivatives and pharmaceutical compositions containing them
PT84399B (en) Process for the preparation of pharmaceutical compositions containing sodium 2-(2,6-dichloroanilino) phenylacetate
PT87301A (pt) Process for the preparation of 1,3-dioxanes by products and of pharmaceutical compounds containing them
PT84339A (pt) 1,6-naphthyridine derivatives process for the preparation thereof and pharmaceutical compositions containing them
PT86964A (pt) Process for the preparation of a fungicidal composition containing 1,10-phenantrolines
PT86623A (pt) Process for the preparation of derivatives of 3-aryl-5-alkylthio-4h-1,2,4-triazoles
FI891111A (fi) Menetelmä 1,4-dihydropyridiinijohdannaisten valmistamiseksi
IL82294A0 (en) 1,3-dihydropyridine derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
FI91069B (fi) Menetelmä 5-C-hydroksimetyylialdoheksoosipohjaisten yhdisteiden valmistamiseksi

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19920416

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20080624